Clinical Trials Browser

Not yet recruiting × Uterine Cervical Neoplasms × nimotuzumab × Clear all

NCT06333821 2024-03-27

A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma

Phase 3 Not yet recruiting

Uterine Cervical Neoplasms

NCT06039891 2023-09-15

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

Phase 2 Not yet recruiting

Uterine Cervical Neoplasms